Immunomodulating Nanomedicine for Cancer Therapy

Zhigang Liu; Wen Jiang; Jutaek Nam; James J. Moon; Betty Y.S. Kim

doi:10.1021/acs.nanolett.8b02340

Immunomodulating Nanomedicine for Cancer Therapy

Zhigang Liu, Wen Jiang, Jutaek Nam, James J. Moon, Betty Y.S. Kim

Research output: Contribution to journal › Article › peer-review

115 Scopus citations

Abstract

Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.

Original language	English (US)
Pages (from-to)	6655-6659
Number of pages	5
Journal	Nano Letters
Volume	18
Issue number	11
DOIs	https://doi.org/10.1021/acs.nanolett.8b02340
State	Published - Nov 14 2018

Keywords

Nanomedicine
cancer immunotherapy
cancer vaccine
drug delivery
nanotechnology

ASJC Scopus subject areas

Bioengineering
General Chemistry
General Materials Science
Condensed Matter Physics
Mechanical Engineering

Access to Document

10.1021/acs.nanolett.8b02340

Cite this

@article{74d4ae430db54d5e8600fcce9dedb489,

title = "Immunomodulating Nanomedicine for Cancer Therapy",

abstract = "Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.",

keywords = "Nanomedicine, cancer immunotherapy, cancer vaccine, drug delivery, nanotechnology",

author = "Zhigang Liu and Wen Jiang and Jutaek Nam and Moon, {James J.} and Kim, {Betty Y.S.}",

note = "Publisher Copyright: {\textcopyright} 2018 American Chemical Society.",

year = "2018",

month = nov,

day = "14",

doi = "10.1021/acs.nanolett.8b02340",

language = "English (US)",

volume = "18",

pages = "6655--6659",

journal = "Nano Letters",

issn = "1530-6984",

publisher = "American Chemical Society",

number = "11",

}

TY - JOUR

T1 - Immunomodulating Nanomedicine for Cancer Therapy

AU - Liu, Zhigang

AU - Jiang, Wen

AU - Nam, Jutaek

AU - Moon, James J.

AU - Kim, Betty Y.S.

PY - 2018/11/14

Y1 - 2018/11/14

N2 - Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.

AB - Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.

KW - Nanomedicine

KW - cancer immunotherapy

KW - cancer vaccine

KW - drug delivery

KW - nanotechnology

UR - http://www.scopus.com/inward/record.url?scp=85053302027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053302027&partnerID=8YFLogxK

U2 - 10.1021/acs.nanolett.8b02340

DO - 10.1021/acs.nanolett.8b02340

M3 - Article

C2 - 30185039

AN - SCOPUS:85053302027

SN - 1530-6984

VL - 18

SP - 6655

EP - 6659

JO - Nano Letters

JF - Nano Letters

IS - 11

ER -

Immunomodulating Nanomedicine for Cancer Therapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this